Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia.

J Oncol · 2022 · PMC9485708 · PMID 36147443

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results showed a trend toward reduced risk of death with pembrolizumab (hazard ratio (HR) 0.74 and 95% confidence interval (95% CI) 0.53–1.03) [ 6 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.